Known Medicine Inc. – Trademark Portfolio

Entity Type: 03

Known Medicine Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include KNOWN 3DX and KNOWN MEDICINE. The owner is based in Salt Lake City, UT.

630 Komas Dr., Suite 300

Salt Lake City, UT 84108

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Known Medicine Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Known Medicine Inc. have?

Known Medicine Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 abandoned.

What trademark classes does Known Medicine Inc. file in?

Known Medicine Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Known Medicine Inc.'s most well-known trademarks?

Known Medicine Inc.'s registered trademark portfolio includes well-known marks such as KNOWN 3DX and KNOWN MEDICINE. These are among 5 currently registered trademarks in the portfolio.

What is Known Medicine Inc.'s trademark registration success rate?

Known Medicine Inc. has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.